content

Enara and Boehringer Ingelheim sign oncology partnership

Enara and Boehringer Ingelheim have teamed up to discover and develop novel cancer immunotherapies against overlooked dark antigen targets. How could dark antigens improve...

CDSCO panel recommends approval for trial of Bharat Biotechs nasal vaccine

Indian drug regulator CDSCOโ€™s subject expert committee has recommended granting permission for conducting Phase I clinical trial of Bharat Biotechโ€™s intranasal Covid-19 vaccine (BBV154). Preclinical...

Nexelis acquires the GSK vaccines clinical bioanalytical laboratory located in Germany

Nexelis, a portfolio company of Ampersand Capital Partners, and a leading provider of advanced assay development and laboratory testing services in the infectious, oncologic,...

Etihad Cargo Reports 50% Y-O-Y Rise in Pharma Shipments

Etihad Cargo, the cargo and logistics arm of Abu Dhabi-based Etihad Aviation Group, has reported a 50 per cent year-on-year rise in pharma shipments...

Lilly, Merus Ink Up-to-$1.6B Bispecific Antibody Partnership vs. Cancer

Eli Lillyโ€™s oncology-focused Loxo Oncology at Lilly will partner with Merus to develop up to three CD3-engaging T-cell re-directing bispecific antibody therapies, through a...

Recipharm signs manufacturing agreement with Enzymatica

Recipharm, a leading contract development and manufacturing organisation (CDMO) and Enzymatica, a Swedish life science company specialising in products with a protective barrier, have...

CPhI & P-MEC China gives a glimpse of the success returning pharma events will deliver in 2021

The recently hosted CPhI & P-MEC China 2020 โ€“ organized by Informa Markets and CCCMHPIE and co-organized by Shanghai Sinoexpo Informa Markets International Exhibition...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read